Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice: A PBRN Clinical Trial
确定牙科实践中牙周辅助抗生素的适应症:PBRN 临床试验
基本信息
- 批准号:10448940
- 负责人:
- 金额:$ 39.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-11 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademyAdultAdverse eventAffectAmericanAmerican Dental AssociationAmoxicillinAntibiotic ResistanceAntibiotic TherapyAntibioticsBiologicalCalibrationCharacteristicsChronicClassificationClinicalClinical DataClinical Practice GuidelineClinical TrialsCombined AntibioticsComparative StudyConflict (Psychology)DataData CollectionData SetDecision MakingDentalDental ClinicsDental General PracticeDental OfficesDentistryDentistsDentitionDevelopmentDiagnosisDisciplineDiseaseDocumentationEnrollmentEvaluationFeasibility StudiesFocus GroupsGoalsGuidelinesHealthHemorrhageIndividualInflammatoryInvestigationLeadLeftLinkLogistic RegressionsManualsMechanicsMedicalMetronidazoleModelingMonitorMorbidity - disease rateNested Case-Control StudyOral cavityParticipantPatient RecruitmentsPatientsPatternPeriodontal DiseasesPeriodontal InfectionPeriodontitisPersonsPhasePlant RootsPopulationPractice GuidelinesPreparationProceduresProtocols documentationRandomizedRandomized Clinical TrialsReportingResistance developmentSampling StudiesShapesSurveysSystemTooth LossTooth root structureTrainingTranslatingTreatment EffectivenessU-Series Cooperative AgreementsUpdateWorkagedbaseclinical practiceclinically significantdesigneffectiveness evaluationefficacy outcomesevidence baseevidence based guidelinesinstrumentpathogenic bacteriapilot testpilot trialprophylacticrecruitresistant strainresponsesecondary outcometranslational potentialtreatment optimizationtreatment responseyears lived with disability
项目摘要
Shaping the Indications for Periodontal Adjunctive Antibiotics in dental practice: A PBRN Clinical Trial
Periodontitis is a bacterial inflammatory disease that has been reported to affect nearly 40% of Americans
aged 30 years or older. If left untreated, periodontitis can lead to tooth loss and patient-perceived morbidity.
Historically, antibiotic use has been an integral part of periodontal disease treatment. However, antibiotic
stewardship calls for rationalizing their prescription to reduce antibiotic misuse and development of resistant
strains. Across medical disciplines, there is a clear direction to identify individuals who in fact may benefit
from antibiotic use and to provide guidelines for their use. As of 2018, the American Dental Association has
developed evidence-based guidelines limiting circumstances for prophylactic antibiotic use in dental
practice; however, no national guidelines exist for antibiotic use in treatment of periodontal infections
because of lack of adequately powered trials assessing disease- and person-specific indications. Thus,
dentists are left to decide when adjunctive antibiotics are indicated, and which dental patients need them to
achieve periodontal health. In the context of periodontitis treatment, a biological rationale exists to support
adjunctive antibiotic use against periodontal pathogenic bacteria, but clinical results of their use have
presented conflicting results. Currently, very limited documentation of the prescription patterns and utilization
of antibiotics as periodontal treatment adjuncts among US practitioners exist. Nonetheless, data from
academic studies suggest that adjunctive systemic antibiotics may only be beneficial for certain populations,
as the biological response to treatment is highly variable across individuals. This marked variability warrants
the identification of person- and/or disease-related characteristics that are linked to maximum benefit from
adjunctive antibiotic treatment. Consequently, clear guidelines can then be established for tailored
indications for their use with the ultimate goal of minimizing antibiotic misuse in periodontal treatment to
avoid development of antibiotic resistance. The objective of this study is to assess the effectiveness of
adjunctive Amoxicillin/Metronidazole combination antibiotics to non-surgical periodontal therapy in clinical
practices within the National Dental PBRN by conducting the largest randomized clinical trial (RCT) of
adjunctive antibiotics. Further, within this PBRN study, current decision-making factors for adjunctive
antibiotic prescription will be surveyed to assess the state of affairs in clinical practice. Importantly,
leveraging the well-powered RCT dataset, high responders to adjunctive antibiotic treatment will be identified
and the predictive validity of decision-making factors currently employed by clinicians will be assessed to
develop clear indications for prescription. Collectively, results of adjunctive antibiotic use at present are
ambiguous because indications are based on empirical information without evidence-based guidelines,
which may lead to antibiotic misuse and lack of efficacy. The present pragmatic well-powered RCT was
designed to enable the development of evidence-based guidelines for periodontal adjunctive antibiotic use.
确定牙周辅助抗生素在牙科实践中的适应症:一项PBRN临床试验
牙周炎是一种细菌性炎症性疾病,据报道,近40%的美国人患有牙周炎
年龄在30岁或以上。如果不治疗,牙周炎可能会导致牙齿脱落和患者感知的发病率。
从历史上看,抗生素的使用一直是牙周病治疗中不可或缺的一部分。然而,抗生素
管理部门要求理顺他们的处方,以减少抗生素的滥用和耐药性的发展
菌株。在医学学科中,有一个明确的方向来确定实际上可能受益的个人
抗生素的使用,并为其使用提供指南。截至2018年,美国牙医协会已
制定循证指南,限制牙科预防性使用抗生素的情况
实践;然而,没有关于在牙周感染治疗中使用抗生素的国家指南
因为缺乏评估疾病和人的特定适应症的充分有力的试验。因此,
牙科医生可以决定何时使用辅助抗生素,以及哪些牙科患者需要使用。
实现牙周健康。在牙周炎治疗的背景下,存在生物学原理来支持
抗牙周病原菌的辅助抗生素使用,但其临床效果
提出了相互矛盾的结果。目前,有关处方模式和使用的文档非常有限
抗生素作为牙周治疗附件在美国从业者中存在。尽管如此,来自
学术研究表明,辅助性全身抗生素可能只对某些人群有益,
因为对治疗的生物反应在不同的人之间是高度不同的。这种明显的变异性证明了
确定与个人和/或疾病相关的特征,从而最大限度地从
辅助抗生素治疗。因此,然后可以为定制建立明确的指导方针
它们的使用适应症,最终目标是尽量减少在牙周治疗中滥用抗生素
避免产生抗药性。这项研究的目的是评估
阿莫西林/甲硝唑联合抗生素在牙周非手术治疗中的临床应用
通过进行最大规模的随机临床试验(RCT)在国家牙科PBRN中的实践
辅助抗生素。此外,在这项PBRN研究中,目前对辅助词的决策因素
将调查抗生素处方,以评估临床实践中的情况。重要的是
利用功能强大的随机对照试验数据集,将确定辅助抗生素治疗的高应答者
临床医生目前使用的决策因素的预测有效性将被评估为
制定明确的处方适应症。总的来说,目前辅助使用抗生素的结果如下
含糊不清是因为适应症是基于经验信息而没有基于证据的指导方针,
这可能会导致抗生素的滥用和疗效的丧失。目前实用的、功能强大的RCT是
旨在为牙周辅助抗生素的使用制定循证指南。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Georgios Kotsakis其他文献
Georgios Kotsakis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Georgios Kotsakis', 18)}}的其他基金
Commensal modulation of Peri-implant Microbiome Dysbiosis via Veillonella parvula
小韦荣球菌对种植体周围微生物群失调的共生调节
- 批准号:
10899342 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice: A PBRN Clinical Trial
确定牙科实践中牙周辅助抗生素的适应症:PBRN 临床试验
- 批准号:
10841855 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
Titanium particle-induced inflammasome activation in the peri-implant mucosal barrier
钛颗粒诱导种植体周围粘膜屏障炎症小体激活
- 批准号:
10360662 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
Titanium particle-induced inflammasome activation in the peri-implant mucosal barrier
钛颗粒诱导种植体周围粘膜屏障炎症小体激活
- 批准号:
10218850 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)